Summit Wealth Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-32,380
Closed -$1K 232
2023
Q1
$1K Buy
+32,380
New +$1.57M 0.02% 141
2021
Q3
Sell
-29
Closed -$2K 187
2021
Q2
$2K Hold
29
﹤0.01% 165
2021
Q1
$1K Buy
+29
New +$1.39K ﹤0.01% 172

Other funds holding SNY

Summit Wealth Group's SNY Position: Q2 2023 in Review

Summit Wealth Group sold out of Sanofi (SNY) in Q2 2023, closing a stake of 32,380 shares — an estimated $1K sold.

Summit Wealth Group first reported a position in SNY in Q1 2021 and held it in 3 quarters. The position peaked at $2K in Q2 2021. 672 funds tracked by Wall St. Rank hold SNY as of Q2 2023.

  • Summit Wealth Group reported no remaining Sanofi position as of Q2 2023 after selling out during the quarter.
  • Summit Wealth Group sold 32,380 Sanofi shares in Q2 2023, an estimated $1K.
  • Summit Wealth Group first reported a position in Sanofi in Q1 2021 and held it in 3 quarters.
  • Summit Wealth Group's Sanofi position peaked at $2K in Q2 2021.
  • 672 funds tracked by Wall St. Rank held Sanofi as of Q2 2023.

Based on Summit Wealth Group's 13F filing for Q2 2023, filed 26 Jul 2023.